Cargando…
Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
Specific stability indicating reverse-phase liquid chromatography (RP-LC) assay method (SIAM) was developed for the determination of cinnarizine (Cinn)/piracetam (Pira) and cinnarizine (Cinn)/heptaminol acefyllinate (Hept) in the presence of the reported degradation products of Cinn. A C(18) column...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795519/ https://www.ncbi.nlm.nih.gov/pubmed/24137049 http://dx.doi.org/10.4137/ACI.S12478 |
_version_ | 1782287385476726784 |
---|---|
author | EL-Houssini, Ola M. Zawilla, Nagwan H. Mohammad, Mohammad A. |
author_facet | EL-Houssini, Ola M. Zawilla, Nagwan H. Mohammad, Mohammad A. |
author_sort | EL-Houssini, Ola M. |
collection | PubMed |
description | Specific stability indicating reverse-phase liquid chromatography (RP-LC) assay method (SIAM) was developed for the determination of cinnarizine (Cinn)/piracetam (Pira) and cinnarizine (Cinn)/heptaminol acefyllinate (Hept) in the presence of the reported degradation products of Cinn. A C(18) column and gradient mobile phase was applied for good resolution of all peaks. The detection was achieved at 210 nm and 254 nm for Cinn/Pira and Cinn/Hept, respectively. The responses were linear over concentration ranges of 20–200, 20–1000 and 25–1000 μgmL(−1) for Cinn, Pira, and Hept respectively. The proposed method was validated for linearity, accuracy, repeatability, intermediate precision, and robustness via statistical analysis of the data. The method was shown to be precise, accurate, reproducible, sensitive, and selective for the analysis of Cinn/Pira and Cinn/Hept in laboratory prepared mixtures and in pharmaceutical formulations. |
format | Online Article Text |
id | pubmed-3795519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-37955192013-10-17 Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products EL-Houssini, Ola M. Zawilla, Nagwan H. Mohammad, Mohammad A. Anal Chem Insights Original Research Specific stability indicating reverse-phase liquid chromatography (RP-LC) assay method (SIAM) was developed for the determination of cinnarizine (Cinn)/piracetam (Pira) and cinnarizine (Cinn)/heptaminol acefyllinate (Hept) in the presence of the reported degradation products of Cinn. A C(18) column and gradient mobile phase was applied for good resolution of all peaks. The detection was achieved at 210 nm and 254 nm for Cinn/Pira and Cinn/Hept, respectively. The responses were linear over concentration ranges of 20–200, 20–1000 and 25–1000 μgmL(−1) for Cinn, Pira, and Hept respectively. The proposed method was validated for linearity, accuracy, repeatability, intermediate precision, and robustness via statistical analysis of the data. The method was shown to be precise, accurate, reproducible, sensitive, and selective for the analysis of Cinn/Pira and Cinn/Hept in laboratory prepared mixtures and in pharmaceutical formulations. Libertas Academica 2013-10-07 /pmc/articles/PMC3795519/ /pubmed/24137049 http://dx.doi.org/10.4137/ACI.S12478 Text en © 2013 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article published under the Creative Commons CC-BY-NC 3.0 license. |
spellingShingle | Original Research EL-Houssini, Ola M. Zawilla, Nagwan H. Mohammad, Mohammad A. Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products |
title | Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products |
title_full | Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products |
title_fullStr | Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products |
title_full_unstemmed | Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products |
title_short | Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products |
title_sort | development and validation of rp-lc method for the determination of cinnarizine/piracetam and cinnarizine/heptaminol acefyllinate in presence of cinnarizine reported degradation products |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795519/ https://www.ncbi.nlm.nih.gov/pubmed/24137049 http://dx.doi.org/10.4137/ACI.S12478 |
work_keys_str_mv | AT elhoussiniolam developmentandvalidationofrplcmethodforthedeterminationofcinnarizinepiracetamandcinnarizineheptaminolacefyllinateinpresenceofcinnarizinereporteddegradationproducts AT zawillanagwanh developmentandvalidationofrplcmethodforthedeterminationofcinnarizinepiracetamandcinnarizineheptaminolacefyllinateinpresenceofcinnarizinereporteddegradationproducts AT mohammadmohammada developmentandvalidationofrplcmethodforthedeterminationofcinnarizinepiracetamandcinnarizineheptaminolacefyllinateinpresenceofcinnarizinereporteddegradationproducts |